Skip to main content
Top
Published in: Neurocritical Care 1/2016

01-08-2016 | Editorial

Decompressive Hemicraniectomy in the Age of Personalized Medicine

Author: Michael N. Diringer

Published in: Neurocritical Care | Issue 1/2016

Login to get access

Excerpt

Ever since the pooled analysis of three randomized controlled trials of early decompressive surgery in malignant infarction of the middle cerebral artery was published in 2007 [1], the consideration of decompressive hemicraniectomy for large hemispheric stroke patients has become widespread. That paper reported on the pooled results of three small randomized trials: DECIMAL [2], DESTINY [3], and HAMLET [4]. While the analysis indicated that the procedure clearly can reduce mortality, considerable controversy persists over whether it improves functional outcome. The essence of the dispute is philosophical and essentially can be distilled down to whether one considers a modified Rankin score of four as a good or a bad outcome. …
Literature
1.
go back to reference Vahedi K, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215–22.CrossRefPubMed Vahedi K, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215–22.CrossRefPubMed
2.
go back to reference Vahedi K, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38(9):2506–17.CrossRefPubMed Vahedi K, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38(9):2506–17.CrossRefPubMed
3.
go back to reference Juttler E, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38(9):2518–25.CrossRefPubMed Juttler E, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38(9):2518–25.CrossRefPubMed
4.
go back to reference Hofmeijer J, et al. Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–33.CrossRefPubMed Hofmeijer J, et al. Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–33.CrossRefPubMed
5.
go back to reference Juttler E, et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med. 2014;370(12):1091–100.CrossRefPubMed Juttler E, et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med. 2014;370(12):1091–100.CrossRefPubMed
6.
go back to reference Wachter D, et al. Cranioplasty after decompressive hemicraniectomy: underestimated surgery-associated complications? Clin Neurol Neurosurg. 2013;115(8):1293–7.CrossRefPubMed Wachter D, et al. Cranioplasty after decompressive hemicraniectomy: underestimated surgery-associated complications? Clin Neurol Neurosurg. 2013;115(8):1293–7.CrossRefPubMed
7.
go back to reference Ewald C, et al. Bone flap necrosis after decompressive hemicraniectomy for malignant middle cerebral artery infarction. Neurocrit Care. 2014;20(1):91–7.CrossRefPubMed Ewald C, et al. Bone flap necrosis after decompressive hemicraniectomy for malignant middle cerebral artery infarction. Neurocrit Care. 2014;20(1):91–7.CrossRefPubMed
8.
9.
go back to reference Ong CJ, Keyrouz SG, Diringer MN. The role of osmotic therapy in hemispheric stroke. Neurocrit Care. 2015;23(2):285–91.CrossRefPubMed Ong CJ, Keyrouz SG, Diringer MN. The role of osmotic therapy in hemispheric stroke. Neurocrit Care. 2015;23(2):285–91.CrossRefPubMed
10.
go back to reference Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998;73(9):829–36.CrossRefPubMed Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998;73(9):829–36.CrossRefPubMed
11.
go back to reference Sheth KN, et al. Glyburide advantage in malignant edema and stroke (GAMES-RP) trial: rationale and design. Neurocrit Care. 2016;24(1):132–9.CrossRefPubMed Sheth KN, et al. Glyburide advantage in malignant edema and stroke (GAMES-RP) trial: rationale and design. Neurocrit Care. 2016;24(1):132–9.CrossRefPubMed
Metadata
Title
Decompressive Hemicraniectomy in the Age of Personalized Medicine
Author
Michael N. Diringer
Publication date
01-08-2016
Publisher
Springer US
Published in
Neurocritical Care / Issue 1/2016
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-016-0295-1

Other articles of this Issue 1/2016

Neurocritical Care 1/2016 Go to the issue